The effects of carnitine on distally-burned dorsal skin flap: An experimental study in rats

Burns

Volumn 29, Issue 3, 2003, Pages 221-227

  Arslan, Emrah ^a   Milcan, Abtullah ^b   Ünal, Sakir ^a   Demirkan, Ferit ^a   Polat, Ayse ^b   Bagdatoglu, Özlen ^b   Aksoy, Alper ^a   Polat, Gürbüz ^b  

^a MERSIN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b MERSIN UNIVERSITY   (Turkey)

Author keywords

Burn; Carnitine; Metabolism; Oxidation; Skin flap

Indexed keywords

ACETYLCHOLINESTERASE; CARNITINE; MALONALDEHYDE; NITRIC OXIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING ORGAN SYSTEMS; BLOOD SAMPLING; BURN; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; HISTOPATHOLOGY; INFLAMMATORY CELL; MICROSCOPY; MUSCLE NECROSIS; NONHUMAN; RAT; SKIN FLAP; SKIN NECROSIS; STATISTICAL ANALYSIS; TISSUE LEVEL; VASCULARIZATION; WOUND HEALING;

EID: 0344837848     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-4179(02)00305-4     Document Type: Article

References (25)

1. Harris R.L., Frenkel R.A., Cottam G.L., Baxter C.R. Lipid metabolism alter thermal trauma. J. Trauma. 22:1982;194.
2. Duke J.H. Jr., Jorgensen S.B., Broell J.R.et al. Contribution of protein to caloric expenditures following injury. Surgery. 68:1970;168.
3. Mitchell M.E. Carnitine metabolism in human subjects. Am. J. Clin. Nutr. 31:1978;293.
4. Tellioglu A.T., Uras K.A., Yilmaz T., Alagözlü H., Tekdemir I., Karabag O. The effect of carnitine on random-pattern flap survival in rats. Plast. Reconstr. Surg. 108:2001;959.
5. Brevetti G., Angelini C., Rosa M.et al. Muscle carnitine deficiency in patients with severe peripheral vascular disease. Circulation. 84:1991;1490.
6. Pepine C.J. The therapeutic potential of carnitine in cardiovascular disorders. Clin. Ther. 13:1991;2.
7. Arsenian M.A. Carnitine and its derivatives in cardiovascular disease. Prog. Cardiovasc. Dis. 40:1997;265.
8. Khouri R.K., Angel M.F., Edstrom L.E. Standardizing the dorsal rat flap. Surg. Forum. 37:1986;590.
9. Walker H.L., McLeod C.G. Jr., Leppla S.H., Mason A.D. Jr. Evaluation of Pseudomonas aeruginosa toxin A in experimental rat burn wound sepsis. Infect. Immun. 25:1979;828.
10. Stumpf D.E., Parker W.D., Angelini C. Carnitine deficiency organic acidemias and Reye's syndrome. Neurology. 35:1985;1041.
11. Okhawa H., Ohishi N., Yagi K. Assay for lipid peroxidation in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95:1979;351.
12. Ido Y., McHowat J., Chang K.C.et al. Neural dysfunction and metabolic imbalances in diabetic rats, prevention by acetyl-carnitine. Diabetes. 43:1994;1469.
13. Brevetti G, Perna S. Metabolic and clinical effects of L-carnitine in peripheral vascular disease. In: Ferrari R, DiMauro S, Sherwood G, editors. L-Carnitine and its role in medicine: from function to therapy. London: Academic Press; 1992. p. 359-78.
14. Hülsmann WC, Dubelaar M-L. Carnitine in metabolism of paced cardiac and skeletal muscles: prevention of acidosis and improvement of vascular flow. In: Ferrari R, DiMauro S, Sherwood G, editors. L-Carnitine and its role in medicine: from function to therapy. London: Academic Press; 1992. p. 345-58.
15. Visioli O, Pasini E, de Giuli F, Ferrari R. Molecular mechanism of action of L-carnitine in treatment of myocardial disorders at the experimental levels. In: Ferrari R, DiMauro S, Sherwood G, editors. L-Carnitine and its role in medicine: from function to therapy. London: Academic Press; 1992. p. 237-63.
16. Mayes PA. Lipids of physiologic. In: Murray RK, Granner DK, Mayes PA, Rodwell VW, editors. Harper's biochemistry. 25th ed. Stamford: Appleton & Lange; 2000. p. 160-71.
17. Aisaka K., Gross S., Griffith O.W.et al. L-Arginine availability determines the duration of acetylcholine induced systemic vasodilatation in vivo. Biochem. Biophys. Res. Commun. 163:1989;710.
18. Murray RK. The biochemical basis of some neuropsychiatric disorders. In: Murray RK, Granner DK, Mayes PA, Rodwell VW, editors. Harper's biochemistry. 25th ed. Stamford: Appleton & Lange; 2000. p. 829-49.
19. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109.
20. Gold M.E., Bush P.A., Ignarro L.J. Depletion of L-arginine causes reversible tolerance to endothelium dependent relaxation. Biochem. Biophys. Res. Commun. 164:1989;714.
21. Kubes I., Suzuki M., Granger D.N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. U.S.A. 88:1991;4651.
22. Abdih H., Kelly C.J., Bouchier-Hayes D. Nitric oxide: (endothelium-derived relaxing factor) attenuates revascularization-induced lung injury. J. Surg. Res. 57:1994;39.
23. Erçöçen A.R., Apaydin I., Emiroglu M., Gültan S.M., Ergün H., Yormuk E. The effects of L-arginine and iloprost on the viability of random skin flaps in rats. Scand. J. Plast. Reconstr. Hand Surg. 32:1998;19.
24. Çetinkale O., Şengül R., Bilgiç R., Bolayirli M., Şenel O., Burçak G. Involvement of neutrophils in ischemic injury. I. Biochemical and histopathologic investigation of the effect of FK506 on dorsal skin flaps in rats. Ann. Plast. Surg. 39:1997;505.
25. Bagdatoglu C., Saray A., Surucu S., Ozturk H., Tamer L. Effect of trapidil in ischemia-reperfusion injury of peripheral nerves. Neurosurgery. 51:2002;212.